Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Computer Motion

This article was originally published in The Gray Sheet

Executive Summary

Zeus robotic surgical system manufacturer anticipates 510(k) clearance for general laparoscopic surgery indication to occur within "the next four to five weeks," Chairman and CEO Bob Duggan tells investors during a July 15 second-quarter earnings call. After receiving clearance, the firm plans to file a 510(k) for thoracic surgery. The company hopes that the two additional indications will even the playing field with competitor Intuitive Surgical (1"The Gray Sheet" March 4, 2002, p. 18). Computer Motion reported sales of $5.1 mil., up 27% over the same period last year, while its net loss was $4.9 mil., down 7%...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel